Congenital Blood Coagulation Factor XIII Deficiency and Perinatal Management

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|5|541-549

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.5, 2005-08, pp. : 541-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood coagulation factor Xa as an emerging drug target

By Borensztajn Keren   Spek C Arnold  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 341-349

Informa Healthcare

Access to resources Recommend Favorite

Ciprofloxacin: Factor XIII deficiency and fatal haemorrhage in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Bivalirudin: Blood coagulation disorders treated with recombinant factor VIIa: case report

By  

Reactions Weekly, Vol. 1, Iss. 1375, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Overview of Blood Coagulation

By  

Hemodialysis International, Vol. 5, Iss. 1, 2001-01 ,pp. : 70-73

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenetic Aspects in Therapeutic Management of Subfoveal Choroidal Neovascularisation: Role of Factor XIII-A 185 T-Allele

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 138-148

Bentham Science Publishers

Access to resources Recommend Favorite